Carelabs KRX:263700KOSDAQ
케어랩스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days3
Articles tracked8since Sep 11
In Q3 2026, Carelabs reported an operating loss of ₩3.6bn. Carelabs (케어랩스) appeared in 0 Korean news articles and 3 DART filings over the past seven days.
Filing signals M&A / stake deal Screener
Carelabs quarterly results consolidated, KRW
| Quarter | Operating profit | Net income |
|---|---|---|
| Q3 2026 | −₩3.6bn | −₩1.0bn |
| Q2 2026 | −₩723m | −₩1.3bn |
| Q1 2026 | ₩675m | −₩196m |
| Q4 2025 derived | −₩5.7bn | −₩4.1bn |
| Q3 2025 | −₩587m | −₩1.1bn |
| Q2 2025 | ₩2.6bn | −₩733m |
| Q1 2025 | ₩841m | ₩25.5bn |
| Q4 2024 derived | −₩3.3bn | −₩11.7bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Carelabs top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.